View in EDS HTML Full Text PDF Full Text

Fusion of SARS-CoV-2 neutralizing LCB1 peptide with Bacillus amyloliquefaciens RNase improves antiviral efficacy.

Saved in:
Bibliographic Details
Title: Fusion of SARS-CoV-2 neutralizing LCB1 peptide with Bacillus amyloliquefaciens RNase improves antiviral efficacy.
Authors: Kostin, Nikita N.1 (AUTHOR), Bobik, Tatyana V.1 (AUTHOR), Konovalova, Elena V.1 (AUTHOR), Kocharovskaya, Milita V.1 (AUTHOR), Simonova, Maria A.1 (AUTHOR), Rushkevich, Natalia Yu1 (AUTHOR), Mokrushina, Yuliana A.1 (AUTHOR), Skryabin, George A.1 (AUTHOR), Kalinin, Roman S.2 (AUTHOR), Kovalchuk, Sergey I.1 (AUTHOR), Ziganshin, Rustam H.1 (AUTHOR), Kaluzhskiy, Leonid A.3 (AUTHOR), Gnedenko, Oksana V.3 (AUTHOR), Yablokov, Evgeniy O.3 (AUTHOR), Ivanov, Alexis S.3 (AUTHOR), Chernov, Aleksandr S.1 (AUTHOR), Kazakov, Vitaly A.1 (AUTHOR), Khokhlova, Oksana N.1 (AUTHOR), Murashev, Arkady N.1 (AUTHOR), Hong, Senlian4 (AUTHOR)
Source: Scientific Reports. 8/5/2025, Vol. 15 Issue 1, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-025-12444-2